BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3608817)

  • 1. Seizure-like activity associated with imipenem-cilastatin.
    Tse CS; Hernandez Vera F; Desai DV
    Drug Intell Clin Pharm; 1987; 21(7-8):659-60. PubMed ID: 3608817
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
    Calandra G; Lydick E; Carrigan J; Weiss L; Guess H
    Am J Med; 1988 May; 84(5):911-8. PubMed ID: 3284342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem: a new carbapenem antibiotic.
    Lipman B; Neu HC
    Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem-cilastatin: the first thienamycin antibiotic.
    Jacobs RF
    Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
    Karadeniz C; Oğuz A; Canter B; Serdaroğlu A
    Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
    Mortimer J; Miller S; Black D; Kwok K; Kirby WM
    Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
    Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
    Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin.
    Barza M
    Eur J Clin Microbiol; 1984 Oct; 3(5):453-5. PubMed ID: 6594233
    [No Abstract]   [Full Text] [Related]  

  • 9. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem.
    Wu Y; Chen K; Shi Z; Wang Q
    Curr Pharm Biotechnol; 2014; 15(8):685-90. PubMed ID: 25051950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem-cilastatin in the treatment of respiratory infections in patients with chronic airways obstruction.
    Wathen CG; Carbarns NJ; Jones PA; Millar A; Croughan MJ; Calder MA; Douglas NJ
    J Antimicrob Chemother; 1988 Jan; 21(1):107-12. PubMed ID: 3356618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
    Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA
    Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem-cilastatin sodium (Primaxin).
    Med Lett Drugs Ther; 1986 Mar; 28(709):29-31. PubMed ID: 3512968
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.
    Hornik CP; Herring AH; Benjamin DK; Capparelli EV; Kearns GL; van den Anker J; Cohen-Wolkowiez M; Clark RH; Smith PB;
    Pediatr Infect Dis J; 2013 Jul; 32(7):748-53. PubMed ID: 23838776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin treatment of bacterial meningitis in children.
    Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS
    Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal model for evaluating the convulsive liability of beta-lactam antibiotics.
    Williams PD; Bennett DB; Comereski CR
    Antimicrob Agents Chemother; 1988 May; 32(5):758-60. PubMed ID: 3395104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primaxin in the treatment of acute bacterial pneumonia in adults.
    Gebhart RJ; Duma RJ; Patterson PM; Bagett JW; Williams DS
    J Antimicrob Chemother; 1985 Feb; 15(2):233-8. PubMed ID: 3980311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.